FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceuticals, namely to an antibacterial humic agent and its use as an antibacterial drug. Antibacterial humic agent contains water and humic substances obtained from humic-containing raw materials selected from a group including leonardite, lignin, coal, peat and/or sapropel, by ultrasonic dispersion of pre-crushed raw materials mixed with water at a temperature of 30-80°C and pressure of 0.05-0.8 MPa, after which the solution is cooled to room temperature and diluted with water to the content of humic substances from 1 to 20 wt. %, while humic substances include humic and fulvic acids and their salts, as well as hydroquinone in an amount not exceeding 3 wt. % of the mass of humic substances.
EFFECT: invention allows obtaining and using a humic agent containing a wide range of humic substances and having no chemical impurities, having an antibacterial effect.
2 cl, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL HUMIC AGENT | 2020 |
|
RU2753609C1 |
COMBINATION OF FULVIC ACID AND ANTIBIOTIC FOR SUPPRESSION OF GROWTH OF BACTERIA RESISTANT TO MAJORITY OF DRUGS, OR TREATMENT OF INFECTIONS CAUSED BY THEM | 2013 |
|
RU2640928C2 |
ANTICOAGULATION HUMIC AGENT FOR IMPROVING RHEOLOGICAL PROPERTIES OF BLOOD | 2020 |
|
RU2756364C1 |
IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
ANTI-INFLAMMATORY HUMIC AGENT | 2020 |
|
RU2756363C1 |
DETOXIFYING HUMIC AGENT | 2020 |
|
RU2756354C1 |
ADAPTOGENIC HUMIC AGENT | 2021 |
|
RU2775079C1 |
HEPATOPROTECTIVE HUMIC AGENT | 2021 |
|
RU2763761C1 |
METHOD OF PRODUCING HUMIC SUBSTANCE EXTRACT | 2019 |
|
RU2720308C1 |
COMBINATION THERAPY FOR TREATING NOSOCOMIAL PNEUMONIA | 2014 |
|
RU2684112C2 |
Authors
Dates
2021-08-18—Published
2020-10-16—Filed